A Study to Evaluate the Efficacy and Safety of HRS-4729 Injection in Obesity

Experimental drug apitegromab aims to prevent muscle loss from weight-loss injections

Apitegromab, a new drug currently in clinical trials, is being developed to prevent muscle loss (often called 'Ozempic butt') caused by GLP-

Study: Obesity Accounts for 1 in 7 Polypharmacy Cases Among Older US Adults

A cross-sectional analysis of a US cohort found that obesity significantly contributes to polypharmacy among older adults. BMI-defined obesi

expert reaction to review of obesity drugs and quality of life / heart health

AI Analysis of Reddit Posts Identifies Potential Side Effects of GLP-1 Weight Loss Drugs

Researchers at the University of Pennsylvania used AI to analyze over 410,000 Reddit posts spanning six years to identify potential side eff

Study finds most weight loss drugs including Wegovy and Mounjaro ‘do not improve quality of life’

A salute to innovation: exenatide in diabetes and obesity drug development at Amylin Pharmaceuticals - Nature Metabolism